

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.66675074 |
| 2 | layer formation in cerebral cortex (GO:0021819) | 4.66041218 |
| 3 | locomotory exploration behavior (GO:0035641) | 4.55996679 |
| 4 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.28419197 |
| 5 | presynaptic membrane assembly (GO:0097105) | 4.25548192 |
| 6 | dermatan sulfate biosynthetic process (GO:0030208) | 4.24913887 |
| 7 | regulation of synapse structural plasticity (GO:0051823) | 4.23594420 |
| 8 | nucleobase catabolic process (GO:0046113) | 4.18147395 |
| 9 | dermatan sulfate metabolic process (GO:0030205) | 4.01769825 |
| 10 | vocalization behavior (GO:0071625) | 3.98749341 |
| 11 | presynaptic membrane organization (GO:0097090) | 3.92522186 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.92498310 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.86780409 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.81550135 |
| 15 | clathrin coat assembly (GO:0048268) | 3.81114282 |
| 16 | exploration behavior (GO:0035640) | 3.71084462 |
| 17 | proline transport (GO:0015824) | 3.67689254 |
| 18 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.59853890 |
| 19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.58248818 |
| 20 | apoptotic cell clearance (GO:0043277) | 3.57730499 |
| 21 | dendrite morphogenesis (GO:0048813) | 3.54649713 |
| 22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.52880829 |
| 23 | positive regulation of axon extension (GO:0045773) | 3.43629228 |
| 24 | sodium ion export (GO:0071436) | 3.42253614 |
| 25 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.40294361 |
| 26 | synaptic vesicle exocytosis (GO:0016079) | 3.37736329 |
| 27 | glutamate secretion (GO:0014047) | 3.32571987 |
| 28 | protein localization to synapse (GO:0035418) | 3.32237141 |
| 29 | dendritic spine morphogenesis (GO:0060997) | 3.31708537 |
| 30 | neuron cell-cell adhesion (GO:0007158) | 3.26466848 |
| 31 | regulation of axon guidance (GO:1902667) | 3.20236756 |
| 32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.15584905 |
| 33 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.15492570 |
| 34 | gamma-aminobutyric acid transport (GO:0015812) | 3.15378531 |
| 35 | chondroitin sulfate catabolic process (GO:0030207) | 3.14445724 |
| 36 | auditory behavior (GO:0031223) | 3.14263314 |
| 37 | activation of protein kinase A activity (GO:0034199) | 3.12779400 |
| 38 | negative regulation of catenin import into nucleus (GO:0035414) | 3.10070457 |
| 39 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.09293580 |
| 40 | negative regulation of cell killing (GO:0031342) | 3.09293580 |
| 41 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.08235106 |
| 42 | cerebellar Purkinje cell layer development (GO:0021680) | 3.05987045 |
| 43 | response to auditory stimulus (GO:0010996) | 3.05428143 |
| 44 | synaptic transmission, glutamatergic (GO:0035249) | 3.03455396 |
| 45 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.00146360 |
| 46 | astrocyte differentiation (GO:0048708) | 3.00041203 |
| 47 | regulation of ARF protein signal transduction (GO:0032012) | 2.99498598 |
| 48 | alanine transport (GO:0032328) | 2.98661045 |
| 49 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.98276560 |
| 50 | axon extension (GO:0048675) | 2.97951048 |
| 51 | membrane assembly (GO:0071709) | 2.96911864 |
| 52 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.95554756 |
| 53 | potassium ion homeostasis (GO:0055075) | 2.91465418 |
| 54 | camera-type eye morphogenesis (GO:0048593) | 2.90259097 |
| 55 | transmission of nerve impulse (GO:0019226) | 2.89365684 |
| 56 | cellular potassium ion homeostasis (GO:0030007) | 2.88773677 |
| 57 | regulation of synaptic vesicle transport (GO:1902803) | 2.87476747 |
| 58 | neuromuscular process controlling balance (GO:0050885) | 2.87271838 |
| 59 | positive regulation of synapse assembly (GO:0051965) | 2.84626359 |
| 60 | postsynaptic membrane organization (GO:0001941) | 2.82688599 |
| 61 | neuron projection regeneration (GO:0031102) | 2.81860575 |
| 62 | neurotransmitter secretion (GO:0007269) | 2.80624935 |
| 63 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.80585347 |
| 64 | neuron recognition (GO:0008038) | 2.79463104 |
| 65 | positive regulation of synapse maturation (GO:0090129) | 2.79416996 |
| 66 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.76738242 |
| 67 | cell migration in hindbrain (GO:0021535) | 2.76281306 |
| 68 | semaphorin-plexin signaling pathway (GO:0071526) | 2.75700042 |
| 69 | axonal fasciculation (GO:0007413) | 2.75178817 |
| 70 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.73583709 |
| 71 | L-amino acid import (GO:0043092) | 2.71644872 |
| 72 | potassium ion import (GO:0010107) | 2.69801788 |
| 73 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.69678852 |
| 74 | cell communication by electrical coupling (GO:0010644) | 2.69635417 |
| 75 | axon ensheathment in central nervous system (GO:0032291) | 2.69476377 |
| 76 | central nervous system myelination (GO:0022010) | 2.69476377 |
| 77 | myelination in peripheral nervous system (GO:0022011) | 2.68726793 |
| 78 | peripheral nervous system axon ensheathment (GO:0032292) | 2.68726793 |
| 79 | neuron projection extension (GO:1990138) | 2.68498838 |
| 80 | cell adhesion mediated by integrin (GO:0033627) | 2.68309292 |
| 81 | astrocyte development (GO:0014002) | 2.65226808 |
| 82 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.64864606 |
| 83 | axon extension involved in axon guidance (GO:0048846) | 2.62827440 |
| 84 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.62827440 |
| 85 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.61638650 |
| 86 | neuronal ion channel clustering (GO:0045161) | 2.58912638 |
| 87 | response to pheromone (GO:0019236) | 2.58586659 |
| 88 | regulation of cholesterol storage (GO:0010885) | 2.58070442 |
| 89 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.57874614 |
| 90 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.57141670 |
| 91 | regulation of axon extension (GO:0030516) | 2.57101348 |
| 92 | negative chemotaxis (GO:0050919) | 2.57073766 |
| 93 | neuron remodeling (GO:0016322) | 2.57043038 |
| 94 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.56959218 |
| 95 | nerve growth factor signaling pathway (GO:0038180) | 2.52609606 |
| 96 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.51473598 |
| 97 | modulation by symbiont of host immune response (GO:0052553) | 2.51473598 |
| 98 | positive regulation by symbiont of host defense response (GO:0052509) | 2.51473598 |
| 99 | modulation by symbiont of host defense response (GO:0052031) | 2.51473598 |
| 100 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.51473598 |
| 101 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.51473598 |
| 102 | protein heterotrimerization (GO:0070208) | 2.50316465 |
| 103 | synaptic vesicle endocytosis (GO:0048488) | 2.50216635 |
| 104 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.50014755 |
| 105 | negative regulation of axon guidance (GO:1902668) | 2.49775794 |
| 106 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.47784382 |
| 107 | spinal cord development (GO:0021510) | 2.47171324 |
| 108 | cellular sodium ion homeostasis (GO:0006883) | 2.46964398 |
| 109 | synapse assembly (GO:0007416) | 2.46270465 |
| 110 | organelle transport along microtubule (GO:0072384) | 2.45183646 |
| 111 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.45105448 |
| 112 | axon regeneration (GO:0031103) | 2.45032767 |
| 113 | regulation of synapse maturation (GO:0090128) | 2.43876296 |
| 114 | axon cargo transport (GO:0008088) | 2.43729282 |
| 115 | establishment of nucleus localization (GO:0040023) | 2.43032195 |
| 116 | negative regulation of microtubule polymerization (GO:0031115) | 2.42647565 |
| 117 | tooth mineralization (GO:0034505) | 2.41696548 |
| 118 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.41057951 |
| 119 | response to nerve growth factor (GO:1990089) | 2.41057951 |
| 120 | positive regulation of fibroblast migration (GO:0010763) | 2.40233552 |
| 121 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.39787964 |
| 122 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.39344028 |
| 123 | mitochondrion transport along microtubule (GO:0047497) | 2.39344028 |
| 124 | positive regulation of dendritic spine development (GO:0060999) | 2.38064417 |
| 125 | vesicle transport along microtubule (GO:0047496) | 2.37665349 |
| 126 | cell proliferation in forebrain (GO:0021846) | 2.36696944 |
| 127 | regulation of axonogenesis (GO:0050770) | 2.35624823 |
| 128 | outer ear morphogenesis (GO:0042473) | 2.35499731 |
| 129 | negative regulation of axon extension (GO:0030517) | 2.35404967 |
| 130 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.35199981 |
| 131 | positive regulation of axonogenesis (GO:0050772) | 2.35197121 |
| 132 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.34638390 |
| 133 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.34460415 |
| 134 | regulation of ARF GTPase activity (GO:0032312) | 2.32990365 |
| 135 | mechanosensory behavior (GO:0007638) | 2.32740415 |
| 136 | dendritic spine organization (GO:0097061) | 2.32415885 |
| 137 | regulation of respiratory system process (GO:0044065) | 2.32331331 |
| 138 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 2.32316287 |
| 139 | amino acid import (GO:0043090) | 2.31345423 |
| 140 | glutamate receptor signaling pathway (GO:0007215) | 2.30635864 |
| 141 | dopamine receptor signaling pathway (GO:0007212) | 2.28970419 |
| 142 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.27629230 |
| 143 | glycine transport (GO:0015816) | 2.27414513 |
| 144 | positive regulation of filopodium assembly (GO:0051491) | 2.27175738 |
| 145 | cerebellar granule cell differentiation (GO:0021707) | 2.24715215 |
| 146 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.23216254 |
| 147 | mating behavior (GO:0007617) | 2.22630368 |
| 148 | regulation of extent of cell growth (GO:0061387) | 2.21748436 |
| 149 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.21663013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.79347372 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.31744876 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.29802925 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.27261887 |
| 5 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.23964531 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.23898870 |
| 7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.17828683 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.15840889 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.15840889 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.14387049 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.09841781 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.06480069 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.03457392 |
| 14 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.00035282 |
| 15 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.96645339 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.96049215 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.94488650 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.94040616 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.80103137 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.78903430 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.77632474 |
| 22 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.75314874 |
| 23 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.74851079 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.74035052 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.73509832 |
| 26 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.72426358 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.71818047 |
| 28 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.70946100 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.69418690 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.65369780 |
| 31 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.65311454 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64110833 |
| 33 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.63536947 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61570485 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.58492048 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.55685301 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52229164 |
| 38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.51888335 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47510901 |
| 40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.47104046 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.45505492 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.45022743 |
| 43 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.44871288 |
| 44 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.39319366 |
| 45 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38521229 |
| 46 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.35598216 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.34152332 |
| 48 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.33986718 |
| 49 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.26561177 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.25818836 |
| 51 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25377857 |
| 52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22959246 |
| 53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22269838 |
| 54 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20929637 |
| 55 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20887950 |
| 56 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.19147637 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18167879 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.18071158 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17059847 |
| 60 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16020743 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15622679 |
| 62 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15107037 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14806300 |
| 64 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12382735 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11529449 |
| 66 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.11518442 |
| 67 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.11518301 |
| 68 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06331794 |
| 69 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05896213 |
| 70 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05411443 |
| 71 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.04941959 |
| 72 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.03968355 |
| 73 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.02922853 |
| 74 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02810563 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02434761 |
| 76 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01928622 |
| 77 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.01304508 |
| 78 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99664759 |
| 79 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99260039 |
| 80 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98815472 |
| 81 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98464226 |
| 82 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98256112 |
| 83 | AR_19668381_ChIP-Seq_PC3_Human | 0.97270929 |
| 84 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97080840 |
| 85 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96253816 |
| 86 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.95936315 |
| 87 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95390007 |
| 88 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.95109001 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94536270 |
| 90 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92834746 |
| 91 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90652207 |
| 92 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.89984846 |
| 93 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.89708076 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.87553168 |
| 95 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.87493107 |
| 96 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86980496 |
| 97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.86882402 |
| 98 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85685634 |
| 99 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.85636674 |
| 100 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.85249496 |
| 101 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.84919933 |
| 102 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.84810439 |
| 103 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84535307 |
| 104 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83779444 |
| 105 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.83708631 |
| 106 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.83315664 |
| 107 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.83247722 |
| 108 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.82635282 |
| 109 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.82328900 |
| 110 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.81211976 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80745962 |
| 112 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.80380179 |
| 113 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80369849 |
| 114 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.80339304 |
| 115 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80018719 |
| 116 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.79877252 |
| 117 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.79869249 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78851371 |
| 119 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.78718201 |
| 120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78600008 |
| 121 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.77983701 |
| 122 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77918215 |
| 123 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.77821584 |
| 124 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.76965033 |
| 125 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.75536863 |
| 126 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.75495370 |
| 127 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.75407123 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74900669 |
| 129 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.73028242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.50731724 |
| 2 | MP0004858_abnormal_nervous_system | 3.34182031 |
| 3 | MP0003329_amyloid_beta_deposits | 3.28311097 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.17337901 |
| 5 | MP0003303_peritoneal_inflammation | 3.16059805 |
| 6 | MP0004270_analgesia | 3.03171719 |
| 7 | MP0000604_amyloidosis | 2.79377954 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.55810637 |
| 9 | MP0009780_abnormal_chondrocyte_physiolo | 2.54636769 |
| 10 | MP0005423_abnormal_somatic_nervous | 2.53523637 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.44719390 |
| 12 | MP0005171_absent_coat_pigmentation | 2.39836185 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.35136724 |
| 14 | MP0005503_abnormal_tendon_morphology | 2.31144016 |
| 15 | MP0002909_abnormal_adrenal_gland | 2.24053811 |
| 16 | MP0003880_abnormal_central_pattern | 2.21723971 |
| 17 | MP0002064_seizures | 2.16386250 |
| 18 | MP0004510_myositis | 2.15497663 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.06906009 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.03337621 |
| 21 | MP0009745_abnormal_behavioral_response | 2.02082044 |
| 22 | MP0002734_abnormal_mechanical_nocicepti | 2.00075185 |
| 23 | MP0005058_abnormal_lysosome_morphology | 1.98994281 |
| 24 | MP0000778_abnormal_nervous_system | 1.98984186 |
| 25 | MP0003075_altered_response_to | 1.96162664 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.85870733 |
| 27 | MP0002249_abnormal_larynx_morphology | 1.84794651 |
| 28 | MP0003690_abnormal_glial_cell | 1.84733171 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.76831857 |
| 30 | MP0009046_muscle_twitch | 1.72548535 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.71076562 |
| 32 | MP0000049_abnormal_middle_ear | 1.70699405 |
| 33 | MP0000534_abnormal_ureter_morphology | 1.68026373 |
| 34 | MP0005409_darkened_coat_color | 1.63995678 |
| 35 | MP0002736_abnormal_nociception_after | 1.63545072 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.60055728 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.58260957 |
| 38 | MP0003634_abnormal_glial_cell | 1.56843766 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.56239109 |
| 40 | MP0003136_yellow_coat_color | 1.55026065 |
| 41 | MP0004885_abnormal_endolymph | 1.50768047 |
| 42 | MP0001970_abnormal_pain_threshold | 1.50660489 |
| 43 | MP0002184_abnormal_innervation | 1.48210683 |
| 44 | MP0009250_abnormal_appendicular_skeleto | 1.47310446 |
| 45 | MP0004130_abnormal_muscle_cell | 1.44480318 |
| 46 | MP0009384_cardiac_valve_regurgitation | 1.42479606 |
| 47 | MP0001440_abnormal_grooming_behavior | 1.39432619 |
| 48 | MP0000955_abnormal_spinal_cord | 1.37323922 |
| 49 | MP0009053_abnormal_anal_canal | 1.37153536 |
| 50 | MP0009379_abnormal_foot_pigmentation | 1.36760044 |
| 51 | MP0003633_abnormal_nervous_system | 1.35572284 |
| 52 | MP0001486_abnormal_startle_reflex | 1.33313548 |
| 53 | MP0003942_abnormal_urinary_system | 1.33116042 |
| 54 | MP0004134_abnormal_chest_morphology | 1.29744687 |
| 55 | MP0005646_abnormal_pituitary_gland | 1.27851408 |
| 56 | MP0004272_abnormal_basement_membrane | 1.27048243 |
| 57 | MP0008569_lethality_at_weaning | 1.24492405 |
| 58 | MP0001348_abnormal_lacrimal_gland | 1.22383316 |
| 59 | MP0005623_abnormal_meninges_morphology | 1.22119412 |
| 60 | MP0002067_abnormal_sensory_capabilities | 1.21016499 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.19980521 |
| 62 | MP0001501_abnormal_sleep_pattern | 1.18937383 |
| 63 | MP0000751_myopathy | 1.18493254 |
| 64 | MP0005508_abnormal_skeleton_morphology | 1.16069341 |
| 65 | MP0002557_abnormal_social/conspecific_i | 1.15538442 |
| 66 | MP0003938_abnormal_ear_development | 1.14905929 |
| 67 | MP0000537_abnormal_urethra_morphology | 1.14493585 |
| 68 | MP0005275_abnormal_skin_tensile | 1.13971992 |
| 69 | MP0002090_abnormal_vision | 1.13180853 |
| 70 | MP0003632_abnormal_nervous_system | 1.11568234 |
| 71 | MP0003631_nervous_system_phenotype | 1.11496742 |
| 72 | MP0009840_abnormal_foam_cell | 1.11426085 |
| 73 | MP0003879_abnormal_hair_cell | 1.10534077 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.10420144 |
| 75 | MP0000678_abnormal_parathyroid_gland | 1.09841292 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 1.08607090 |
| 77 | MP0001299_abnormal_eye_distance/ | 1.06062300 |
| 78 | MP0002882_abnormal_neuron_morphology | 1.05576482 |
| 79 | MP0002116_abnormal_craniofacial_bone | 1.05465895 |
| 80 | MP0000026_abnormal_inner_ear | 1.05460168 |
| 81 | MP0005076_abnormal_cell_differentiation | 1.01858338 |
| 82 | MP0000428_abnormal_craniofacial_morphol | 1.01702083 |
| 83 | MP0005166_decreased_susceptibility_to | 1.01601457 |
| 84 | MP0003091_abnormal_cell_migration | 1.01381817 |
| 85 | MP0008961_abnormal_basal_metabolism | 1.01093830 |
| 86 | MP0002066_abnormal_motor_capabilities/c | 1.00556662 |
| 87 | MP0005386_behavior/neurological_phenoty | 0.96961062 |
| 88 | MP0004924_abnormal_behavior | 0.96961062 |
| 89 | MP0002822_catalepsy | 0.95899421 |
| 90 | MP0002272_abnormal_nervous_system | 0.95730319 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.95458306 |
| 92 | MP0001963_abnormal_hearing_physiology | 0.94854045 |
| 93 | MP0001958_emphysema | 0.94847063 |
| 94 | MP0002998_abnormal_bone_remodeling | 0.94281156 |
| 95 | MP0003385_abnormal_body_wall | 0.94050322 |
| 96 | MP0000733_abnormal_muscle_development | 0.93434647 |
| 97 | MP0002152_abnormal_brain_morphology | 0.93084269 |
| 98 | MP0003861_abnormal_nervous_system | 0.92932061 |
| 99 | MP0005595_abnormal_vascular_smooth | 0.92588524 |
| 100 | MP0003122_maternal_imprinting | 0.92309288 |
| 101 | MP0000920_abnormal_myelination | 0.92192590 |
| 102 | MP0000631_abnormal_neuroendocrine_gland | 0.91535531 |
| 103 | MP0010030_abnormal_orbit_morphology | 0.91452989 |
| 104 | MP0003436_decreased_susceptibility_to | 0.91123774 |
| 105 | MP0001905_abnormal_dopamine_level | 0.90571132 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.90030389 |
| 107 | MP0001485_abnormal_pinna_reflex | 0.89637405 |
| 108 | MP0002932_abnormal_joint_morphology | 0.86629890 |
| 109 | MP0000762_abnormal_tongue_morphology | 0.86583946 |
| 110 | MP0002108_abnormal_muscle_morphology | 0.84457623 |
| 111 | MP0001984_abnormal_olfaction | 0.83716879 |
| 112 | MP0005257_abnormal_intraocular_pressure | 0.82667423 |
| 113 | MP0003283_abnormal_digestive_organ | 0.82475101 |
| 114 | MP0002752_abnormal_somatic_nervous | 0.82198800 |
| 115 | MP0005187_abnormal_penis_morphology | 0.81846367 |
| 116 | MP0005248_abnormal_Harderian_gland | 0.78007237 |
| 117 | MP0000579_abnormal_nail_morphology | 0.77404302 |
| 118 | MP0002653_abnormal_ependyma_morphology | 0.76607870 |
| 119 | MP0001849_ear_inflammation | 0.73830846 |
| 120 | MP0002089_abnormal_postnatal_growth/wei | 0.73346830 |
| 121 | MP0002139_abnormal_hepatobiliary_system | 0.72035727 |
| 122 | MP0003045_fibrosis | 0.71965629 |
| 123 | MP0002419_abnormal_innate_immunity | 0.70066457 |
| 124 | MP0003566_abnormal_cell_adhesion | 0.64577129 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.64565854 |
| 126 | MP0003279_aneurysm | 0.62943585 |
| 127 | MP0008874_decreased_physiological_sensi | 0.62926907 |
| 128 | MP0005535_abnormal_body_temperature | 0.61670058 |
| 129 | MP0006082_CNS_inflammation | 0.61068522 |
| 130 | MP0006276_abnormal_autonomic_nervous | 0.59168444 |
| 131 | MP0001502_abnormal_circadian_rhythm | 0.59004583 |
| 132 | MP0001177_atelectasis | 0.58977620 |
| 133 | MP0002229_neurodegeneration | 0.58905318 |
| 134 | MP0005645_abnormal_hypothalamus_physiol | 0.58845496 |
| 135 | MP0003448_altered_tumor_morphology | 0.56709744 |
| 136 | MP0003183_abnormal_peptide_metabolism | 0.56061131 |
| 137 | MP0005387_immune_system_phenotype | 0.56002127 |
| 138 | MP0001790_abnormal_immune_system | 0.56002127 |
| 139 | MP0009278_abnormal_bone_marrow | 0.55043447 |
| 140 | MP0000747_muscle_weakness | 0.53907685 |
| 141 | MP0004085_abnormal_heartbeat | 0.53062497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mutism (HP:0002300) | 4.70640700 |
| 2 | Supranuclear gaze palsy (HP:0000605) | 4.33882104 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 4.31776081 |
| 4 | Neurofibrillary tangles (HP:0002185) | 3.69576489 |
| 5 | Papilledema (HP:0001085) | 3.61675974 |
| 6 | Protrusio acetabuli (HP:0003179) | 3.60856011 |
| 7 | Cerebral inclusion bodies (HP:0100314) | 3.52465352 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.48953728 |
| 9 | Apathy (HP:0000741) | 3.40995697 |
| 10 | Disinhibition (HP:0000734) | 3.39500715 |
| 11 | Visual hallucinations (HP:0002367) | 3.29658790 |
| 12 | Shallow orbits (HP:0000586) | 3.23698800 |
| 13 | Myokymia (HP:0002411) | 3.20532349 |
| 14 | Premature rupture of membranes (HP:0001788) | 3.19513154 |
| 15 | Morphological abnormality of the middle ear (HP:0008609) | 3.18504964 |
| 16 | Diminished motivation (HP:0000745) | 3.15714756 |
| 17 | Neonatal short-limb short stature (HP:0008921) | 2.98606381 |
| 18 | Inappropriate behavior (HP:0000719) | 2.92439385 |
| 19 | Dysostosis multiplex (HP:0000943) | 2.91819878 |
| 20 | Glomerulonephritis (HP:0000099) | 2.85247512 |
| 21 | Focal seizures (HP:0007359) | 2.81964004 |
| 22 | Action tremor (HP:0002345) | 2.79636392 |
| 23 | Aplasia involving bones of the extremities (HP:0009825) | 2.75488486 |
| 24 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.75488486 |
| 25 | Aplasia of the phalanges of the hand (HP:0009802) | 2.75488486 |
| 26 | Short 4th metacarpal (HP:0010044) | 2.71312948 |
| 27 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.71312948 |
| 28 | Mucopolysacchariduria (HP:0008155) | 2.63094660 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.63094660 |
| 30 | Abnormality of binocular vision (HP:0011514) | 2.59829170 |
| 31 | Diplopia (HP:0000651) | 2.59829170 |
| 32 | Amyotrophic lateral sclerosis (HP:0007354) | 2.59058939 |
| 33 | Loss of speech (HP:0002371) | 2.56595744 |
| 34 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.55162931 |
| 35 | Abnormality of the 4th metacarpal (HP:0010012) | 2.54765584 |
| 36 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.53850581 |
| 37 | Neuronal loss in central nervous system (HP:0002529) | 2.53338644 |
| 38 | Vascular tortuosity (HP:0004948) | 2.47135261 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.46494904 |
| 40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.46494904 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.46494904 |
| 42 | Akinesia (HP:0002304) | 2.45593575 |
| 43 | Complement deficiency (HP:0004431) | 2.42934375 |
| 44 | Hemiplegia (HP:0002301) | 2.42898286 |
| 45 | Coronal craniosynostosis (HP:0004440) | 2.42043222 |
| 46 | Agitation (HP:0000713) | 2.39790262 |
| 47 | Hypoventilation (HP:0002791) | 2.38464464 |
| 48 | Ankle clonus (HP:0011448) | 2.36695540 |
| 49 | Polyphagia (HP:0002591) | 2.36410203 |
| 50 | Mild short stature (HP:0003502) | 2.36219040 |
| 51 | Elfin facies (HP:0004428) | 2.36162429 |
| 52 | Hand muscle atrophy (HP:0009130) | 2.36057351 |
| 53 | Bowel diverticulosis (HP:0005222) | 2.35902058 |
| 54 | Abnormality of complement system (HP:0005339) | 2.35121096 |
| 55 | Torticollis (HP:0000473) | 2.32266968 |
| 56 | Cerebral aneurysm (HP:0004944) | 2.31850614 |
| 57 | Enlarged penis (HP:0000040) | 2.29403012 |
| 58 | Focal motor seizures (HP:0011153) | 2.27714164 |
| 59 | Obstructive sleep apnea (HP:0002870) | 2.27149225 |
| 60 | Renal duplication (HP:0000075) | 2.23430066 |
| 61 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.22070684 |
| 62 | Renovascular hypertension (HP:0100817) | 2.22068664 |
| 63 | Termporal pattern (HP:0011008) | 2.22048377 |
| 64 | Insidious onset (HP:0003587) | 2.22048377 |
| 65 | Abnormal eating behavior (HP:0100738) | 2.21811425 |
| 66 | Hyperacusis (HP:0010780) | 2.19160656 |
| 67 | Overriding aorta (HP:0002623) | 2.18991925 |
| 68 | Atrophic scars (HP:0001075) | 2.18273633 |
| 69 | Bronchomalacia (HP:0002780) | 2.18202695 |
| 70 | Morphological abnormality of the inner ear (HP:0011390) | 2.16852581 |
| 71 | Hemiparesis (HP:0001269) | 2.16812366 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16531350 |
| 73 | Upper limb amyotrophy (HP:0009129) | 2.15594710 |
| 74 | Distal upper limb amyotrophy (HP:0007149) | 2.15594710 |
| 75 | Cortical dysplasia (HP:0002539) | 2.14952069 |
| 76 | Depression (HP:0000716) | 2.10875864 |
| 77 | Mitral regurgitation (HP:0001653) | 2.09947643 |
| 78 | Asymmetric septal hypertrophy (HP:0001670) | 2.09658964 |
| 79 | Abnormality of the diencephalon (HP:0010662) | 2.08621579 |
| 80 | Sleep apnea (HP:0010535) | 2.06372357 |
| 81 | Abnormality of the lower motor neuron (HP:0002366) | 2.06100460 |
| 82 | Septo-optic dysplasia (HP:0100842) | 2.06012378 |
| 83 | Abnormality of glycolipid metabolism (HP:0010969) | 2.05828433 |
| 84 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.05828433 |
| 85 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.05828433 |
| 86 | Peripheral hypomyelination (HP:0007182) | 2.05815357 |
| 87 | Insomnia (HP:0100785) | 2.05473543 |
| 88 | Soft skin (HP:0000977) | 2.05037702 |
| 89 | Ankle contracture (HP:0006466) | 2.04975215 |
| 90 | J-shaped sella turcica (HP:0002680) | 2.03742577 |
| 91 | Cutaneous finger syndactyly (HP:0010554) | 2.03027668 |
| 92 | Peritonitis (HP:0002586) | 2.01476461 |
| 93 | Hypoplasia of the iris (HP:0007676) | 2.00665649 |
| 94 | Drooling (HP:0002307) | 2.00473305 |
| 95 | Excessive salivation (HP:0003781) | 2.00473305 |
| 96 | Flat cornea (HP:0007720) | 1.98891429 |
| 97 | Generalized tonic-clonic seizures (HP:0002069) | 1.98491776 |
| 98 | Rapidly progressive (HP:0003678) | 1.98432698 |
| 99 | Turricephaly (HP:0000262) | 1.97998695 |
| 100 | Abnormality of dentin (HP:0010299) | 1.97508248 |
| 101 | Megalencephaly (HP:0001355) | 1.97409447 |
| 102 | Biconcave vertebral bodies (HP:0004586) | 1.95254689 |
| 103 | Abnormality of the corticospinal tract (HP:0002492) | 1.94989150 |
| 104 | Postural instability (HP:0002172) | 1.94796430 |
| 105 | Genetic anticipation (HP:0003743) | 1.94692289 |
| 106 | Fragile skin (HP:0001030) | 1.91732180 |
| 107 | Vitreoretinal degeneration (HP:0000655) | 1.91491856 |
| 108 | Aortic dissection (HP:0002647) | 1.91200059 |
| 109 | Epileptic encephalopathy (HP:0200134) | 1.90746020 |
| 110 | Poor eye contact (HP:0000817) | 1.89492003 |
| 111 | Wide anterior fontanel (HP:0000260) | 1.88491255 |
| 112 | Spinal rigidity (HP:0003306) | 1.86695497 |
| 113 | Shawl scrotum (HP:0000049) | 1.86306587 |
| 114 | Lower limb amyotrophy (HP:0007210) | 1.86271139 |
| 115 | Impaired social interactions (HP:0000735) | 1.86108614 |
| 116 | Abnormal social behavior (HP:0012433) | 1.86108614 |
| 117 | Megalocornea (HP:0000485) | 1.85366647 |
| 118 | Progressive cerebellar ataxia (HP:0002073) | 1.84781823 |
| 119 | Cutaneous syndactyly (HP:0012725) | 1.84090663 |
| 120 | Synostosis of carpal bones (HP:0005048) | 1.83939147 |
| 121 | Hyperextensible skin (HP:0000974) | 1.82211804 |
| 122 | Macroorchidism (HP:0000053) | 1.82173233 |
| 123 | Focal dystonia (HP:0004373) | 1.80261288 |
| 124 | Aqueductal stenosis (HP:0002410) | 1.79597152 |
| 125 | Stereotypic behavior (HP:0000733) | 1.79073195 |
| 126 | Deviation of the hallux (HP:0010051) | 1.78687213 |
| 127 | Anomalous pulmonary venous return (HP:0010772) | 1.78683296 |
| 128 | Craniofacial dystonia (HP:0012179) | 1.77670267 |
| 129 | Subacute progressive viral hepatitis (HP:0006572) | 1.77396136 |
| 130 | Broad metatarsal (HP:0001783) | 1.77220246 |
| 131 | Wrist flexion contracture (HP:0001239) | 1.76873353 |
| 132 | Truncal ataxia (HP:0002078) | 1.76132900 |
| 133 | Wormian bones (HP:0002645) | 1.75954571 |
| 134 | Polygenic inheritance (HP:0010982) | 1.74529113 |
| 135 | Abnormality of the pulmonary veins (HP:0011718) | 1.73911577 |
| 136 | Arterial tortuosity (HP:0005116) | 1.73826362 |
| 137 | Hallux valgus (HP:0001822) | 1.73636390 |
| 138 | Nephritis (HP:0000123) | 1.73108333 |
| 139 | Increased corneal curvature (HP:0100692) | 1.72783086 |
| 140 | Keratoconus (HP:0000563) | 1.72783086 |
| 141 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.71742877 |
| 142 | Dementia (HP:0000726) | 1.70750892 |
| 143 | Urinary urgency (HP:0000012) | 1.70574532 |
| 144 | Ulnar bowing (HP:0003031) | 1.70434042 |
| 145 | Mitral valve prolapse (HP:0001634) | 1.70239283 |
| 146 | Tibial bowing (HP:0002982) | 1.69531153 |
| 147 | Absence seizures (HP:0002121) | 1.68424043 |
| 148 | Limb dystonia (HP:0002451) | 1.67213739 |
| 149 | Increased variability in muscle fiber diameter (HP:0003557) | 1.65002230 |
| 150 | Bladder diverticulum (HP:0000015) | 1.63906978 |
| 151 | Lymphangioma (HP:0100764) | 1.63797723 |
| 152 | Vacuolated lymphocytes (HP:0001922) | 1.63514895 |
| 153 | Overgrowth (HP:0001548) | 1.63421441 |
| 154 | Confusion (HP:0001289) | 1.63333548 |
| 155 | Progressive inability to walk (HP:0002505) | 1.62986768 |
| 156 | Vertebral arch anomaly (HP:0008438) | 1.62779864 |
| 157 | Myotonia (HP:0002486) | 1.62578181 |
| 158 | Genu recurvatum (HP:0002816) | 1.62400148 |
| 159 | Bowing of the arm (HP:0006488) | 1.61306973 |
| 160 | Bowed forearm bones (HP:0003956) | 1.61306973 |
| 161 | Arnold-Chiari malformation (HP:0002308) | 1.59319200 |
| 162 | Anxiety (HP:0000739) | 1.57286791 |
| 163 | Partial duplication of the phalanx of hand (HP:0009999) | 1.56507591 |
| 164 | Intention tremor (HP:0002080) | 1.56506205 |
| 165 | Aortic regurgitation (HP:0001659) | 1.55604458 |
| 166 | Heterochromia iridis (HP:0001100) | 1.52703435 |
| 167 | Venous insufficiency (HP:0005293) | 1.52120718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.71061618 |
| 2 | MAP3K9 | 3.48156561 |
| 3 | CASK | 2.95913239 |
| 4 | TRIB3 | 2.69063347 |
| 5 | DAPK2 | 2.57679579 |
| 6 | CAMKK1 | 2.27706127 |
| 7 | MINK1 | 2.23476514 |
| 8 | RIPK1 | 2.17056911 |
| 9 | PHKG2 | 2.16947766 |
| 10 | PHKG1 | 2.16947766 |
| 11 | PKN2 | 2.11005240 |
| 12 | PAK6 | 2.08915946 |
| 13 | NTRK2 | 2.04426064 |
| 14 | NTRK3 | 1.99015584 |
| 15 | TNIK | 1.95901458 |
| 16 | LATS2 | 1.88413520 |
| 17 | SIK2 | 1.79393438 |
| 18 | NTRK1 | 1.78754947 |
| 19 | PRKD2 | 1.67825448 |
| 20 | KSR2 | 1.64648404 |
| 21 | MAP3K4 | 1.60449253 |
| 22 | CAMK1G | 1.56128117 |
| 23 | PRKD3 | 1.30836667 |
| 24 | RET | 1.28719311 |
| 25 | CAMK1D | 1.25932224 |
| 26 | TAOK1 | 1.24568580 |
| 27 | EPHB2 | 1.22458924 |
| 28 | ERN1 | 1.22167630 |
| 29 | SCYL2 | 1.21203524 |
| 30 | PRKCH | 1.20722582 |
| 31 | CAMKK2 | 1.20027528 |
| 32 | MAP2K4 | 1.19774580 |
| 33 | CDK5 | 1.19472020 |
| 34 | ERBB3 | 1.17310617 |
| 35 | MST1R | 1.16717625 |
| 36 | RIPK4 | 1.16416265 |
| 37 | BMX | 1.16223684 |
| 38 | STK38 | 1.14728289 |
| 39 | KSR1 | 1.13942112 |
| 40 | SGK223 | 1.11761187 |
| 41 | SGK494 | 1.11761187 |
| 42 | MOS | 1.11075033 |
| 43 | FES | 1.10051741 |
| 44 | CAMK2B | 1.06506202 |
| 45 | DYRK2 | 1.06480694 |
| 46 | EPHA4 | 1.04802295 |
| 47 | MAP2K7 | 1.03753491 |
| 48 | ROCK2 | 1.03716328 |
| 49 | ALK | 1.01414074 |
| 50 | PLK2 | 1.01180597 |
| 51 | ERBB4 | 1.00184200 |
| 52 | MAPK13 | 0.96621184 |
| 53 | PTK6 | 0.96301149 |
| 54 | PAK2 | 0.95072734 |
| 55 | TTN | 0.94336184 |
| 56 | RPS6KA2 | 0.94181913 |
| 57 | EPHA3 | 0.93611962 |
| 58 | PDGFRA | 0.92307967 |
| 59 | FGFR2 | 0.91588126 |
| 60 | TYRO3 | 0.90519157 |
| 61 | MAP3K2 | 0.88012476 |
| 62 | PINK1 | 0.85850735 |
| 63 | DDR2 | 0.85824857 |
| 64 | LMTK2 | 0.85685036 |
| 65 | DAPK1 | 0.84086223 |
| 66 | SGK2 | 0.83120453 |
| 67 | PAK3 | 0.82986311 |
| 68 | CAMK2G | 0.82557837 |
| 69 | CSNK1G2 | 0.81978997 |
| 70 | FGR | 0.75486825 |
| 71 | MARK2 | 0.74934670 |
| 72 | LIMK1 | 0.74849737 |
| 73 | PNCK | 0.73137521 |
| 74 | PRKCG | 0.72939380 |
| 75 | MAPK12 | 0.72325686 |
| 76 | GRK5 | 0.71024906 |
| 77 | STK11 | 0.70827010 |
| 78 | PRKCZ | 0.69452551 |
| 79 | BLK | 0.69032556 |
| 80 | PKN1 | 0.68327236 |
| 81 | MTOR | 0.65359336 |
| 82 | CDK14 | 0.64672973 |
| 83 | * FYN | 0.64187296 |
| 84 | ICK | 0.63759649 |
| 85 | CDK15 | 0.63219749 |
| 86 | CAMK1 | 0.60983224 |
| 87 | ARAF | 0.60249182 |
| 88 | CDK18 | 0.59906814 |
| 89 | DMPK | 0.59325659 |
| 90 | JAK1 | 0.58990225 |
| 91 | CAMK2D | 0.57673093 |
| 92 | SGK1 | 0.55707071 |
| 93 | PRKD1 | 0.55340634 |
| 94 | MAPK4 | 0.54441344 |
| 95 | ROCK1 | 0.54048213 |
| 96 | CSNK1A1L | 0.53734965 |
| 97 | MAPK10 | 0.52093899 |
| 98 | TBK1 | 0.51788900 |
| 99 | FGFR4 | 0.50738007 |
| 100 | CDK11A | 0.50565551 |
| 101 | HCK | 0.50464289 |
| 102 | GRK1 | 0.49316476 |
| 103 | NEK6 | 0.48548696 |
| 104 | CSNK1G3 | 0.48413158 |
| 105 | PDPK1 | 0.47720803 |
| 106 | ABL2 | 0.47637307 |
| 107 | ERBB2 | 0.46885311 |
| 108 | MAP3K1 | 0.46488063 |
| 109 | EGFR | 0.45496325 |
| 110 | UHMK1 | 0.45388849 |
| 111 | DYRK1A | 0.44499648 |
| 112 | SGK3 | 0.43968773 |
| 113 | DAPK3 | 0.43385472 |
| 114 | TESK1 | 0.43109862 |
| 115 | MUSK | 0.42896437 |
| 116 | PRPF4B | 0.42817556 |
| 117 | EPHB1 | 0.42723758 |
| 118 | SRC | 0.41067519 |
| 119 | CAMK2A | 0.40804216 |
| 120 | PDGFRB | 0.40520602 |
| 121 | PRKCE | 0.39894871 |
| 122 | PDK1 | 0.39563593 |
| 123 | PTK2 | 0.39142756 |
| 124 | CDC42BPA | 0.38807159 |
| 125 | KIT | 0.38766032 |
| 126 | PTK2B | 0.38664782 |
| 127 | JAK2 | 0.38502892 |
| 128 | NEK9 | 0.38022678 |
| 129 | SIK1 | 0.38008379 |
| 130 | CSNK1G1 | 0.37830381 |
| 131 | FGFR3 | 0.37385381 |
| 132 | RPS6KA3 | 0.36356745 |
| 133 | MAPKAPK5 | 0.35579357 |
| 134 | EEF2K | 0.35322343 |
| 135 | RPS6KL1 | 0.34079191 |
| 136 | RPS6KC1 | 0.34079191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.11051657 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.06880012 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 1.96994035 |
| 4 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.92485167 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.85318588 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 1.62710409 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 1.60818865 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.56144703 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 1.50698412 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.49835594 |
| 11 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.49100333 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 1.45599358 |
| 13 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.45584384 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.44442927 |
| 15 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.41420528 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.37516574 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.36928235 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.35769526 |
| 19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.34306676 |
| 20 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.33865574 |
| 21 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.33506401 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.32474084 |
| 23 | Axon guidance_Homo sapiens_hsa04360 | 1.32209455 |
| 24 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.28528763 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.28136790 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.27138313 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.23839722 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.23585611 |
| 29 | Glioma_Homo sapiens_hsa05214 | 1.22651238 |
| 30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.22428917 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.21517273 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20096011 |
| 33 | Melanoma_Homo sapiens_hsa05218 | 1.19668219 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.18942659 |
| 35 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.17303136 |
| 36 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.16611154 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.15633981 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13015552 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.12693044 |
| 40 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.12621604 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09428587 |
| 42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09402914 |
| 43 | Insulin secretion_Homo sapiens_hsa04911 | 1.08789193 |
| 44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.07467427 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.05222659 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.05060565 |
| 47 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.03143862 |
| 48 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.00206887 |
| 49 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.99948629 |
| 50 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.99466374 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99022899 |
| 52 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.98496823 |
| 53 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98394627 |
| 54 | Long-term depression_Homo sapiens_hsa04730 | 0.96221527 |
| 55 | Amoebiasis_Homo sapiens_hsa05146 | 0.94981957 |
| 56 | Tuberculosis_Homo sapiens_hsa05152 | 0.94348417 |
| 57 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.94275620 |
| 58 | Endometrial cancer_Homo sapiens_hsa05213 | 0.93013766 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.91424647 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90806326 |
| 61 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.90428820 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.90383919 |
| 63 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89981517 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89114985 |
| 65 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.89002324 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87767480 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86902134 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.86508704 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85893165 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85752784 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85348959 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.85139052 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84835807 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84365206 |
| 75 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.83926921 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83616905 |
| 77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82872861 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82592812 |
| 79 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82591918 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80589979 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80097864 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79505999 |
| 83 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.79331761 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.78725305 |
| 85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.76459385 |
| 86 | Melanogenesis_Homo sapiens_hsa04916 | 0.76023936 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75299184 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.74961494 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.73241378 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72597025 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71677564 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.71498997 |
| 93 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71230314 |
| 94 | Bile secretion_Homo sapiens_hsa04976 | 0.71211789 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.70560608 |
| 96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70339450 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.70006071 |
| 98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68993173 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.68586051 |
| 100 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68421635 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.68013339 |
| 102 | Tight junction_Homo sapiens_hsa04530 | 0.67504278 |
| 103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66698342 |
| 104 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.66657090 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66645880 |
| 106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66330672 |
| 107 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.65001397 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63433580 |
| 109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.62781678 |
| 110 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62753103 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62523287 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61398453 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61363366 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.60970837 |
| 115 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60691905 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60678600 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59699884 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59394277 |
| 119 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.58406478 |
| 120 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58018152 |
| 121 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57906057 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57471465 |
| 123 | Insulin resistance_Homo sapiens_hsa04931 | 0.57378553 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54827191 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53336878 |
| 126 | Taste transduction_Homo sapiens_hsa04742 | 0.52950230 |
| 127 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52621373 |
| 128 | Phototransduction_Homo sapiens_hsa04744 | 0.50165169 |
| 129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46519254 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45347891 |
| 131 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.44236913 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44033116 |

